Pharma Case Highlights Importance Of Unrebutted Evidence

On Nov. 1, 2017, the Federal Circuit reversed Judge Gregory Sleet's (District of Delaware) decision that Bayer's asserted patent was not invalid for obviousness. Bayer Pharma AG et al. v. Watson...

Already a subscriber? Click here to view full article